第一三共の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2013/01/16 | 1,456 | 1,469 | 1,446 | 1,452 | -2 | -0.1% | 3,726,300 |
2013/01/15 | 1,440 | 1,454 | 1,436 | 1,454 | +31 | +2.2% | 3,248,300 |
2013/01/11 | 1,395 | 1,426 | 1,395 | 1,423 | +31 | +2.2% | 3,284,200 |
2013/01/10 | 1,379 | 1,394 | 1,378 | 1,392 | +17 | +1.2% | 2,580,400 |
2013/01/09 | 1,366 | 1,382 | 1,359 | 1,375 | +13 | +1% | 2,429,100 |
2013/01/08 | 1,371 | 1,371 | 1,358 | 1,362 | -7 | -0.5% | 2,205,800 |
2013/01/07 | 1,378 | 1,379 | 1,365 | 1,369 | +8 | +0.6% | 2,229,000 |
2013/01/04 | 1,349 | 1,362 | 1,344 | 1,361 | +39 | +3% | 2,996,200 |
2012/12/28 | 1,325 | 1,328 | 1,316 | 1,322 | +1 | +0.1% | 1,772,500 |
2012/12/27 | 1,320 | 1,332 | 1,316 | 1,321 | +1 | +0.1% | 2,541,400 |
2012/12/26 | 1,315 | 1,320 | 1,311 | 1,320 | +8 | +0.6% | 1,383,400 |
2012/12/25 | 1,320 | 1,321 | 1,307 | 1,312 | +3 | +0.2% | 1,593,500 |
2012/12/21 | 1,321 | 1,321 | 1,306 | 1,309 | -1 | -0.1% | 2,231,000 |
2012/12/20 | 1,320 | 1,322 | 1,307 | 1,310 | -12 | -0.9% | 3,753,700 |
2012/12/19 | 1,310 | 1,322 | 1,304 | 1,322 | +22 | +1.7% | 2,919,800 |
2012/12/18 | 1,297 | 1,303 | 1,295 | 1,300 | +2 | +0.2% | 2,192,000 |
2012/12/17 | 1,303 | 1,314 | 1,293 | 1,298 | +2 | +0.2% | 2,475,200 |
2012/12/14 | 1,288 | 1,303 | 1,285 | 1,296 | ±0 | ±0% | 4,599,000 |
2012/12/13 | 1,300 | 1,302 | 1,291 | 1,296 | +1 | +0.1% | 1,530,700 |
2012/12/12 | 1,300 | 1,303 | 1,294 | 1,295 | ±0 | ±0% | 1,426,400 |
2012/12/11 | 1,287 | 1,295 | 1,287 | 1,295 | +7 | +0.5% | 1,178,800 |
2012/12/10 | 1,289 | 1,291 | 1,284 | 1,288 | ±0 | ±0% | 1,260,700 |
2012/12/07 | 1,282 | 1,289 | 1,282 | 1,288 | +7 | +0.5% | 1,276,600 |
2012/12/06 | 1,283 | 1,290 | 1,280 | 1,281 | +2 | +0.2% | 1,851,700 |
2012/12/05 | 1,275 | 1,285 | 1,273 | 1,279 | -2 | -0.2% | 1,989,700 |
2012/12/04 | 1,276 | 1,284 | 1,272 | 1,281 | +8 | +0.6% | 1,810,800 |
2012/12/03 | 1,278 | 1,280 | 1,266 | 1,273 | +1 | +0.1% | 1,345,200 |
2012/11/30 | 1,267 | 1,285 | 1,262 | 1,272 | +10 | +0.8% | 2,579,100 |
2012/11/29 | 1,261 | 1,266 | 1,256 | 1,262 | +7 | +0.6% | 1,212,200 |
2012/11/28 | 1,260 | 1,270 | 1,254 | 1,255 | -11 | -0.9% | 1,620,400 |
2012/11/27 | 1,263 | 1,272 | 1,260 | 1,266 | +12 | +1% | 1,863,400 |
2012/11/26 | 1,264 | 1,275 | 1,231 | 1,254 | -13 | -1% | 3,126,400 |
2012/11/22 | 1,259 | 1,268 | 1,253 | 1,267 | +28 | +2.3% | 2,600,800 |
2012/11/21 | 1,245 | 1,246 | 1,232 | 1,239 | +5 | +0.4% | 1,438,600 |
2012/11/20 | 1,241 | 1,245 | 1,233 | 1,234 | +1 | +0.1% | 1,367,600 |
2012/11/19 | 1,210 | 1,237 | 1,210 | 1,233 | +21 | +1.7% | 1,997,600 |
2012/11/16 | 1,213 | 1,221 | 1,204 | 1,212 | -3 | -0.2% | 2,395,900 |
2012/11/15 | 1,202 | 1,215 | 1,195 | 1,215 | +8 | +0.7% | 1,619,500 |
2012/11/14 | 1,191 | 1,210 | 1,189 | 1,207 | +9 | +0.8% | 1,172,500 |
2012/11/13 | 1,193 | 1,199 | 1,185 | 1,198 | +6 | +0.5% | 2,020,500 |
2012/11/12 | 1,200 | 1,204 | 1,191 | 1,192 | -19 | -1.6% | 2,456,300 |
2012/11/09 | 1,208 | 1,220 | 1,207 | 1,211 | -1 | -0.1% | 1,994,600 |
2012/11/08 | 1,202 | 1,213 | 1,201 | 1,212 | -1 | -0.1% | 1,332,500 |
2012/11/07 | 1,231 | 1,233 | 1,210 | 1,213 | -11 | -0.9% | 2,313,900 |
2012/11/06 | 1,226 | 1,237 | 1,222 | 1,224 | -4 | -0.3% | 1,269,500 |
2012/11/05 | 1,247 | 1,249 | 1,225 | 1,228 | -32 | -2.5% | 1,653,100 |
2012/11/02 | 1,257 | 1,267 | 1,252 | 1,260 | +8 | +0.6% | 1,897,200 |
2012/11/01 | 1,233 | 1,260 | 1,222 | 1,252 | +32 | +2.6% | 2,607,100 |
2012/10/31 | 1,219 | 1,225 | 1,206 | 1,220 | -10 | -0.8% | 3,034,100 |
2012/10/30 | 1,215 | 1,234 | 1,213 | 1,230 | +21 | +1.7% | 4,453,800 |
2901~
2950
件表示中 / 3586件
類似銘柄と比較する
現在ご覧いただいている「第一三共」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
第一三共 | 443,500円 | +14.3% | +20.1% | 1.35% | 37.27倍 | 5.17倍 |
|
国内製薬大手。循環器と感染症薬強い。英アストラゼネカ社と提携し、がん領域の開拓中 |
中外薬 | 627,000円 | +3.5% | +21.7% | 1.31% | 26.59倍 | 5.89倍 |
|
ロシュ傘下で成長続ける異色の医薬品大手。抗体・バイオで先行、抗がん剤、骨・関節領域に強い |
武 田 | 411,300円 | +5.1% | +76.2% | 4.77% | 95.87倍 | 0.94倍 |
|
国内製薬首位。がん、中枢神経、消化器、希少疾患等に重点。巨額買収で世界売上上位10強入り |
大塚HD | 891,000円 | +14.4% | +120.8% | 1.35% | 20.00倍 | 1.83倍 |
|
国内製薬大手で抗精神病薬が主力。ポカリスエットなど機能性食品も拡大。世界90カ所に工場 |
アステラス薬 | 156,200円 | +12.2% | +180.3% | 4.74% | 55.93倍 | 1.83倍 |
|
医薬品国内2位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
市場注目の銘柄
チャート関連のコラム